In these last ten years medicine has tremendously developed, due to the introduction of new technologies, which have completely changed both diagnostics and therapies. In this new scenario a very innovative trend is represented by diagnostic imaging, where "light" technologies - such as ultrasound systems or magnetic resonance imaging - can offer less invasive solutions together with high standards of efficacy and new tools for helping the diagnosis and the treatment of diseases.
In order to develop the most innovative, non-invasive and cost-effective diagnostic technologies, like ultrasound and dedicated MRI, Esaote started its activity in the early 1980s. Since its inception Esaote has always greatly invested in the activities of research, in order to develop these "light" technologies, with the aim of improving the quality of life and, at the same time, of contributing not only to the success of the Group but also to the achievement of new goals in technologies as well as in medical-scientific innovation.
Esaote considers of top priority to supply its customers with more and more innovative and reliable products while pursuing the ethical principles of the market in which the Company operates in compliance with the existing laws.
Perfectly aware to operate in a sector featuring a highly social value, since its very beginning the Company adopted the concept of "creativity in healthcare", which represents its daily commitment in innovation in order to:
- introduce as many as possible new ideas and methods in products, services and internal procedures in compliance with the company peculiarities
- develop processes and products which can meet the sought-after reliability level
- improve the costs/performances ratio for products, processes and services
- create value, in order to increase credibility and confidence of its own investors, while pursuing adequate development trends
